Post-transplant cyclophosphamide versus antithymocyte globulin in patients with acute myeloid leukemia in first complete remission undergoing allogeneic stem cell transplantation from 10/10 HLA-matched unrelated donors

BACKGROUND: Graft-versus-host disease (GVHD) remains a major contributor to mortality and morbidity after allogeneic stem-cell transplantation (allo-HSCT). The updated recommendations suggest that rabbit antithymocyte globulin or anti-T-lymphocyte globulin (ATG) should be used for GVHD prophylaxis i...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Hematol Oncol
Main Authors: Brissot, Eolia, Labopin, Myriam, Moiseev, Ian, Cornelissen, J. J., Meijer, Ellen, Van Gorkom, Gwendolyn, Rovira, Montserrat, Ciceri, Fabio, Griskevicius, Laimonas, Blaise, Didier, Forcade, Edouard, Mistrik, Martin, Mielke, Stephan, Bulabois, Claude Eric, Niittyvuopio, Riitta, Deconinck, Eric, Ruggeri, Annalisa, Sanz, Jaime, Spyridonidis, Alexandros, Savani, Bipin, Giebel, Sebastian, Nagler, Arnon, Mohty, Mohamad
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2020
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7333262/
https://ncbi.nlm.nih.gov/pubmed/32620146
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13045-020-00923-0
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados